SAMSRITA LABS LIMITED (SAMSRITA.BO)
INR 22.97
(4.98%)
INR 22.97
(4.98%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 22.03 Million INR | 6.15% |
| 2022 | 20.75 Million INR | -24.27% |
| 2021 | 27.4 Million INR | 17.1% |
| 2020 | 23.4 Million INR | -72.73% |
| 2019 | 85.84 Million INR | 8.41% |
| 2018 | 79.18 Million INR | 16.36% |
| 2017 | 68.05 Million INR | 4.68% |
| 2016 | 65 Million INR | 0.0% |
| 2015 | - INR | 0.0% |
| 2014 | - INR | 0.0% |
| 2013 | - INR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q4 | 22.03 Million INR | 0.0% |
| 2023 FY | 22.03 Million INR | 6.15% |
| 2023 Q2 | 21.68 Million INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q2 | 28.91 Million INR | 0.0% |
| 2022 Q4 | 20.75 Million INR | 0.0% |
| 2022 FY | 20.75 Million INR | -24.27% |
| 2022 Q3 | - INR | -100.0% |
| 2021 FY | 27.4 Million INR | 17.1% |
| 2021 Q4 | 27.4 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q2 | 96.16 Million INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2020 FY | 23.4 Million INR | -72.73% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q2 | 89.57 Million INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q4 | 93.94 Million INR | 0.0% |
| 2019 Q2 | 79.99 Million INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 FY | 85.84 Million INR | 8.41% |
| 2019 Q1 | - INR | 0.0% |
| 2019 Q4 | 85.84 Million INR | 0.0% |
| 2018 FY | 79.18 Million INR | 16.36% |
| 2017 FY | 68.05 Million INR | 4.68% |
| 2016 Q2 | - INR | 0.0% |
| 2016 Q3 | - INR | 0.0% |
| 2016 Q4 | 65 Million INR | 0.0% |
| 2016 FY | 65 Million INR | 0.0% |
| 2015 FY | - INR | 0.0% |
| 2014 FY | - INR | 0.0% |
| 2014 Q1 | - INR | 0.0% |
| 2014 Q4 | - INR | 0.0% |
| 2013 FY | - INR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 1.35 Billion INR | 98.376% |
| Biocon Limited | 162.76 Billion INR | 99.986% |
| Blue Jet Healthcare Limited | 16.12 Million INR | -36.59% |
| Concord Biotech Limited | 97.37 Million INR | 77.374% |
| Dishman Carbogen Amcis Limited | 23.12 Billion INR | 99.905% |
| FERMENTA BIOTECH LIMITED | 1.32 Billion INR | 98.334% |
| GENOMIC VALLEY BIOTECH LIMITED | - INR | -Infinity% |
| Lyka Labs Limited | 586.5 Million INR | 96.243% |
| Panacea Biotec Limited | 209.9 Million INR | 89.504% |
| Servoteach Industries Limited | 5059.00 INR | -435401.087% |
| SMS Lifesciences India Limited | 1 Billion INR | 97.813% |
| Supriya Lifescience Limited | 54.88 Million INR | 59.854% |
| Syngene International Limited | 5.55 Billion INR | 99.603% |
| TAKE Solutions Limited | 370.85 Million INR | 94.059% |
| Titan Biotech Limited | 83.02 Million INR | 73.465% |
| Transgene Biotek Limited | 140.01 Million INR | 84.264% |
| Vanta Bioscience Limited | 609.53 Million INR | 96.385% |